Clinical trial
Intravenous Clarithromycin in Septic Syndrome
NCT00297674 · University of Athens, Other · Completed
Key facts
| NCT number | NCT00297674 |
|---|---|
| Title | Intravenous Clarithromycin in Septic Syndrome |
| Official title | Clarithromycin as Immunomodulatory Therapy for the Management of Septic Syndrome by Ventilator-Associated Pneumonia |
| Lead sponsor | University of Athens, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sepsis, Ventilator Associated Pneumonia |
| Intervention type | Drug |
| Interventions | Intravenous Clarithromycin |
| Enrollment | 200 |
| Start date | Jun 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Feb 28, 2006 |
| Last update posted | Feb 28, 2006 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: